Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Profound Medical | PROF | Aug 30, 2024 | 9.15 | -2.03 |
ProFrac A | ACDC | Aug 30, 2024 | 6.85 | +1.18 |
PROG | PRG | Aug 30, 2024 | 46.76 | -0.34 |
Progress Software | PRGS | Aug 30, 2024 | 58.15 | -0.19 |
Progressive | PGR | Aug 30, 2024 | 252.20 | +0.88 |
Progyny | PGNY | Aug 30, 2024 | 23.49 | +6.05 |
Project Energy Reimagined Acquisition A | PEGR | Aug 30, 2024 | 9.73 | 0.00 |
Project Energy Reimagined Acquisition Unit | PEGRU | Aug 30, 2024 | 11.10 | 0.00 |
ProKidney | PROK | Aug 30, 2024 | 2.40 | +0.84 |
Prologis | PLD | Aug 30, 2024 | 127.82 | +1.99 |
ProMIS Neurosciences | PMN | Aug 30, 2024 | 1.37 | +5.09 |
PropertyGuru | PGRU | Aug 30, 2024 | 6.57 | 0.00 |
ProPetro | PUMP | Aug 30, 2024 | 7.94 | -2.46 |
ProPhase Labs | PRPH | Aug 30, 2024 | 2.69 | +12.08 |
ProQR Therapeutics | PRQR | Aug 30, 2024 | 2.02 | +1.51 |
PROS | PRO | Aug 30, 2024 | 20.13 | +0.60 |
ProShares Bitcoin Strategy ETF | BITO | Aug 30, 2024 | 19.00 | -1.09 |
Proshares Ultra FTSE Europe | UPV | Aug 30, 2024 | 69.28 | +0.50 |
ProShares UltraShort Bloomberg Natural Gas | KOLD | Aug 30, 2024 | 77.60 | +3.00 |
Proshares Ultrashort FTSE Europe | EPV | Aug 30, 2024 | 6.91 | -0.29 |
Prospect Capital | PSEC | Aug 30, 2024 | 5.23 | +4.60 |
Prospect Capital A Pref | PSEC-A | Aug 30, 2024 | 18.13 | -5.77 |
Prosperity Bancshares | PB | Aug 30, 2024 | 73.58 | +0.82 |
Protagenic Therapeutics | PTIX | Aug 30, 2024 | 0.61 | +4.10 |
Protagonist Therapeutics | PTGX | Aug 30, 2024 | 42.89 | +1.42 |
Protalix Bio Therapeutics | PLX | Aug 30, 2024 | 0.94 | +3.75 |
Protara Therapeutics | TARA | Aug 30, 2024 | 2.00 | -0.99 |
Prothena | PRTA | Aug 30, 2024 | 22.27 | +3.29 |
Proto Labs | PRLB | Aug 30, 2024 | 30.58 | +1.83 |
Provident Bancorp | PVBC | Aug 30, 2024 | 11.03 | +1.10 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.